USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Search results for: 'secure web gateway frost radar'
- Related search terms
- frost amp sullivan's accountsignout helpcontactsitemap healthcare home research events blog forum peerconnect tags switch community
- frost amp sullivan believes that global nsps are investing between 50 billion and (6(6 billion) annually on their mobile and wireles
- Frost & Sullivan: Global and Chinese Pharmaceutical Market Research Report
- Frost Radar™: Point-of-Care Ultrasound Imaging Technology Ecosystem, 2026
- frost sullivan global ad chinese pharmaceutical market research report
-
28 Oct 2024 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step approach to market commercialization, with a clear understanding of the market stakeholders, segments, and post-launch forecasts to create seamless go-to-market strategies, develop a positive image, and instill confidence among healthcare pr...
$4,950.00
Special Price $4,207.50 save 15 %
-
16 Jan 2025 | Global | Technology Research
Advanced Therapeutics for the Infectious Disease Management Market, Global, 2024-2029
The emergence of novel pathogens and the reemergence of old pathogens are driving transformational growth by pushing therapeutic advancement.
Antimicrobial resistance (AMR), the emergence of new pathogens, and breakthroughs in biotechnology have significantly transformed the global landscape of infectious diseases. This Frost & Sullivan report focuses on advanced therapeutics for the infectious disease management industry. It offers an analysis of clinical trials for 3 treatment modaliti...
$4,950.00
Special Price $4,207.50 save 15 %
-
01 Mar 2024 | North America | Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00
Special Price $3,712.50 save 25 %
